Exchange: NASDAQ·Updated 12:14 PM EDT
LITS logo

LITS Lite Strategy, Inc.

$1.01
$0.0245
(2.49%)
Today
EarningsSep 28
Mkt Cap$33.53M
Vol35,722.00

About LITS

Lite Strategy, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. Its programs include Voruciclib and ME-344. The company was founded on December 1, 2000, and is headquartered in San Diego, CA.
71

Bullish Sentiment

How do you feel about LITS?

Advertisement|Remove ads.